Highlights

Anondita to attend Pharma Eurasia 2026. Mr. Anupam Ghosh emphasizes international expansion. Aims to boost global presence through partnerships.

Latest news

Honest Thoughts on B.Sc Agriculture - Is It Worth It in 2026?

Honest Thoughts on B.Sc Agriculture - Is It Worth It in 2026?

Petroleum coke shortage may hit aluminium production outside Gulf too: JP Morgan

Petroleum coke shortage may hit aluminium production outside Gulf too: JP Morgan

Monika Alcobev Limited reports strong FY26 growth; PAT rises 39.07% and revenue from operations reaches ₹301.16 crore

Monika Alcobev Limited reports strong FY26 growth; PAT rises 39.07% and revenue from operations reaches ₹301.16 crore

"Don't depend on what the country can do for us, what we can do for the country?" Uday Kotak to India Inc

"Don't depend on what the country can do for us, what we can do for the country?" Uday Kotak to India Inc

CEA Nageswaran advocates for trade skills integration to scale MSMEs into global value chains

CEA Nageswaran advocates for trade skills integration to scale MSMEs into global value chains

Uday Kotak backs PM Modi's austerity push, warns of coming energy shock

Uday Kotak backs PM Modi's austerity push, warns of coming energy shock

Top Courses To Study Abroad

Top Courses To Study Abroad

Peach Blossoms Celebrates Three Massive Wins - Black Pearl Restaurant Guide 2026, Asia's 50 Best Restaurants 2026 Extended List and Tatler Best 20 Restaurants in Singapore 2026

Peach Blossoms Celebrates Three Massive Wins - Black Pearl Restaurant Guide 2026, Asia's 50 Best Restaurants 2026 Extended List and Tatler Best 20 Restaurants in Singapore 2026

Anondita Medicare Limited to Participate in Pharma Eurasia 2026, Uzbekistan

Anondita Medicare Limited will participate in Pharma Eurasia 2026, targeting expansion in Central Asia by showcasing its products, and leveraging partnership potential.

Anondita Medicare Limited to Participate in Pharma Eurasia 2026, Uzbekistan

VMPL
Mumbai (Maharashtra) [India], May 12: Anondita Medicare Limited (NSE - SME: ANONDITA) has announced its participation in "Pharma Eurasia 2026, Uzbekistan", scheduled to be held from 20th May 2026 to 22nd May 2026 at Tashkent Pharma Park, Tashkent, Uzbekistan.
The Company will participate in the exhibition with the objective of expanding its presence across Central Asian countries and exploring business opportunities, including engagement with potential buyers.
Strategic Impact
- Strengthening the Company's presence across Central Asian markets
- Exploring engagement opportunities with potential buyers and channel partners
- Showcasing the Company's manufacturing capabilities and product portfolio in international markets
- Expanding global business visibility through participation in a leading pharmaceutical industry exhibition

Management Commentary
Commenting on the development, Mr. Anupam Ghosh, Managing Director, Anondita Medicare Limited, said: "Our participation in Pharma Eurasia 2026 reflects our continued focus on expanding our international presence and engaging with potential business partners across emerging markets. The exhibition provides an opportunity to showcase our manufacturing capabilities and explore growth opportunities in Central Asia."
About Anondita Medicare Limited
Anondita Medicare Limited, is an Indian manufacturer of condoms, operating under its flagship brand "COBRA." The company runs its own manufacturing facility and follows a quality-driven, compliant production model. The company is led by Mr. Anupam Ghosh, who brings over 25 years of experience in the healthcare and contraceptive products industry. His deep domain expertise,
entrepreneurial background, and execution capability provide strong leadership and strategic direction to the company.
With a strong domestic presence, particularly in North India, Anondita Medicare is actively expanding its geographical footprint across India and international markets. Ongoing initiatives such as automation-led capacity enhancement, and patented female condom products position the company for scalable growth and long-term value creation.
Disclaimer
Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local, political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. The Company will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances
For more information, please visit:
Anondita Medicare Limited
www.anonditamedicare.com
www.cobrastore.in
(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same.)

(This article was generated from news agency ANI without modifications to the text.)

ADVERTISEMENT

Up Next

Anondita Medicare Limited to Participate in Pharma Eurasia 2026, Uzbekistan

Anondita Medicare Limited to Participate in Pharma Eurasia 2026, Uzbekistan

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

Reliance denies buying Iranian oil amid US sanctions waiver

Reliance denies buying Iranian oil amid US sanctions waiver

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates

India's GDP expected to register over 8 pc growth in Sep-Dec: Report

India's GDP expected to register over 8 pc growth in Sep-Dec: Report

Govt announces seven measures to help boost exports

Govt announces seven measures to help boost exports

ADVERTISEMENT

editorji-whatsApp

More videos

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI pauses rate cuts, retains interest rate at 5.25 pc

RBI pauses rate cuts, retains interest rate at 5.25 pc

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

UPI transactions hit record high of Rs 230 lakh crore in 2025-26 till Dec: Govt

UPI transactions hit record high of Rs 230 lakh crore in 2025-26 till Dec: Govt

Explained: India-US trade deal, tariffs and trade benefits

Explained: India-US trade deal, tariffs and trade benefits

Trade deal with US adds momentum to India's growth ambition: Industry leaders

Trade deal with US adds momentum to India's growth ambition: Industry leaders

Rupee jumps 119 paise to 90.30 against the US dollar on India-US trade deal

Rupee jumps 119 paise to 90.30 against the US dollar on India-US trade deal

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.